Logo Annals of Transplantation Logo Annals of Transplantation Logo Annals of Transplantation

01 January 2003

The impact of pretransplant erythropoietin therapy on late outcomes of renal transplantation.

Katarzyna Lietz, Mieczysław Lao, Leszek Paczek, Andrzej Górski, Zbigniew Gaciong

Ann Transplant 2003; 8(2): 17-24 :: ID: 142807

Abstract

OBJECTIVES: The introduction of recombinant erythropoietin (rHu-EPO) hasbeen shown to reverse anemia of chronic renal failure and was able to almost completely obviate the needfor repeated blood transfusions (BT), the most potent cause of allostimulation in renal transplant candidates.The series describes single center experience of the pretransplant BT and rHu-EPO therapy effects onlate outcomes of cadaveric renal transplantation. METHODS: We retrospectively analyzed data of 502 adultrecipients of primary renal allograft between 1990-1997 whose graft survived > 6 months. In the studygroup 51 patients were treated prior to transplantation with de novo rHu-EPO therapy, 207 patients receivedBT, 184 patients were switched from BT to rHu-EPO therapy, and 60 patients did not require treatment.The groups were compared in respect to pretransplant % PRA, frequency of acute rejections and graft survival.RESULTS: At one-year graft survival was similar between groups, however at five years recipients of denovo rHu-EPO and those who have converted from BT to rHu-EPO experienced only 7% graft loss, as comparedto 22% of patients treated with BT, and 18% of patients who did not require treatment, p < 0.001. Thepretransplant therapy with rHu-EPO was associated with decreased frequency of late episodes of rejectionfrom 0.42 to 0.27, p = 0.03. There were no differences between groups in the number of highly sensitized(PRA > 20%) at the time of transplantation. CONCLUSIONS: The use of rHu-EPO as de novo therapy or conversionfrom BT treatment to rHu-EPO prior to transplantation was associated with a decline in late posttransplantalloreactivity and improved late renal graft survival.

Add Comment 0 Comments

In Press

08 Mar 2024 : Original article  

Association of Coronary Calcium Score on Cardiac PET During Pre-Kidney Transplant Assessment with Persisten...

Ann Transplant In Press; DOI: 10.12659/AOT.943532  

14 Mar 2024 : Original article  

Impact of Blood Products Transfusion on Patients in the Immediate Post-Lung Transplant Period: A Cohort Study

Ann Transplant In Press; DOI: 10.12659/AOT.943652  

14 Mar 2024 : Case report  

Treatment of Cavernous Transformation of Portal Vein Caused by Hepatic Cystic Echinococcosis Using Ex Vivo ...

Ann Transplant In Press; DOI: 10.12659/AOT.942358  

15 Mar 2024 : Review article  

Approaches and Challenges in the Current Management of Cytomegalovirus in Transplant Recipients: Highlighti...

Ann Transplant In Press; DOI: 10.12659/AOT.941185  

Most Viewed Current Articles

05 Apr 2022 : Original article  

Impact of Statins on Hepatocellular Carcinoma Recurrence After Living-Donor Liver Transplantation

DOI :10.12659/AOT.935604

Ann Transplant 2022; 27:e935604

12 Jan 2022 : Original article  

Risk Factors for Developing BK Virus-Associated Nephropathy: A Single-Center Retrospective Cohort Study of ...

DOI :10.12659/AOT.934738

Ann Transplant 2022; 27:e934738

22 Nov 2022 : Original article  

Long-Term Effects of Everolimus-Facilitated Tacrolimus Reduction in Living-Donor Liver Transplant Recipient...

DOI :10.12659/AOT.937988

Ann Transplant 2022; 27:e937988

15 Mar 2022 : Case report  

Combined Liver, Pancreas-Duodenum, and Kidney Transplantation for Patients with Hepatitis B Cirrhosis, Urem...

DOI :10.12659/AOT.935860

Ann Transplant 2022; 27:e935860

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Annals of Transplantation eISSN: 2329-0358
Annals of Transplantation eISSN: 2329-0358